CD79A and nasopharyngeal carcinoma: Previous studies have shown that young patients with NPC have less expression of p53 and Bcl-2, two key proteins that control the balance of apoptotic survival, and less IgA anti-EA and anti-VCA antibodies [21], and more C-kit receptors and EBV-related cancer protein LMP1 [22].